Confusing AF

Now that twitter has recovered from its downtime, a catch-up tweetorial on apixaban for AF in patients on dialysis for you.

Many nephrologists make decisions about which anticoagulant (if any) to recommend for atrial fibrillation in patients on haemodialysis on a weekly basis.

And we finally have more randomised data!

Enjoy a rapid catch-up with #TenTweetNephJC pic.twitter.com/r99aAqPeiV

— Nephrology Journal Club (@NephJC) March 6, 2023

Freely Filtered does MyTEMP

Episode 043: In this episode we chill out and discuss why it may not be necessary to make patients uncomfortably cool to prevent cardiovascular badness. The lead author Amit Garg joins us to break it down.

SODIUM-HF in Kidney Medicine

The NephJC editorial in Kidney Medicine is live. Great work from Sheikh Khalid, Rachel Hung, and William Vasquez Espinosa, supported by Nayan, Joel, and Jamie.
Read it here.

View fullsize

Water, Water Everywhere: The Diuretic Wars Continue!

What’s your loop and thiazide of choice? Do you know which diuretics are better, faster, stronger? This week’s TenTweets is a two-fer (Chlorthalidone vs HCTZ and Furosemide vs Torsemide). Tweetorial catch-up here.

Welcome to #TenTweetNephJC

✳️10 tweets #NephJC catch-up ✳️

We all have our “go to” diuretics that are better, faster, stronger…but are they?
What evidence is there that one diuretic (in a class) is superior to another for CV outcomes?
It’s a 2-fer TenTweets.
Let’s go… pic.twitter.com/9Ms3zg8Z5z

— Nephrology Journal Club (@NephJC) February 10, 2023

The TRANSFORM-HF Visual Abstract

Does Torsemide lower all cause mortality compared to furosemide for heart failure patients post-hospitalization? Cristina Popa elaborates, visually!

View fullsize

The Diuretic Comparison Project Visual Abstract

Is Chlorthalidone superior to Hydrochlorothiazide in preventing major adverse cardiovascular events? Here is the VA from Mike Turk

View fullsize

The good news is there was a huge trial in Alport syndrome published

The bad news is it was on bardoxolone. Tweetorial catch-up here.

✳️ #TenTweetNephJC ✳️

This week CARDINAL - the largest ever RCT in patients with Alport Syndrome 🧵👇 pic.twitter.com/wrAxJoz1GJ

— Nephrology Journal Club (@NephJC) January 28, 2023

Freely Filtered does STOP ACE

Episode 055: The Filtrate try to figure out STOP ACE with the assistance of Laurie Tomlinson.

The CARDINAL Visual Abstract

Does Bardoxolone help patients with Alport’s Syndrome? Dr M Abdul Qader explains graphically.

View fullsize

IgA and steroids: the saga continues

Drug reps pitching you Nefecon? Catch-up with the RCT in our #TenTweetNephJC tweetorial

#TenTweetNephJC returns in 2023! Catch-up rapidly with the biggest trials in nephrology.

Up first is NefIgArd.

We all say we hate steroids, but really we love their efficacy but hate their side-effects, right?

IgA nephropathy is again the subject of a steroid trial🧵 pic.twitter.com/sh0xtKPhsP

— Nephrology Journal Club (@NephJC) January 20, 2023